These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule. Cai H; Shi Q; Tang Y; Chen L; Chen Y; Tao Z; Yang H; Xie F; Wu X; Liu N; Yang Y; Wu H; Tian R; Lu X; Li L Mol Pharm; 2019 May; 16(5):1950-1957. PubMed ID: 30986347 [TBL] [Abstract][Full Text] [Related]
24. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758 [TBL] [Abstract][Full Text] [Related]
26. Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model. Natarajan A; Habte F; Gambhir SS Bioconjug Chem; 2012 Jun; 23(6):1221-9. PubMed ID: 22621257 [TBL] [Abstract][Full Text] [Related]
27. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals. Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491 [TBL] [Abstract][Full Text] [Related]
28. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET. Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418 [TBL] [Abstract][Full Text] [Related]
29. In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with Muns JA; Montserrat V; Houthoff HJ; Codée-van der Schilden K; Zwaagstra O; Sijbrandi NJ; Merkul E; van Dongen GAMS J Nucl Med; 2018 Jul; 59(7):1146-1151. PubMed ID: 29496986 [TBL] [Abstract][Full Text] [Related]
30. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. Ruggiero A; Holland JP; Hudolin T; Shenker L; Koulova A; Bander NH; Lewis JS; Grimm J J Nucl Med; 2011 Oct; 52(10):1608-15. PubMed ID: 21908391 [TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry. Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446 [TBL] [Abstract][Full Text] [Related]
33. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250 [TBL] [Abstract][Full Text] [Related]
34. A Systematic Evaluation of Antibody Modification and Sharma SK; Glaser JM; Edwards KJ; Khozeimeh Sarbisheh E; Salih AK; Lewis JS; Price EW Bioconjug Chem; 2021 Jul; 32(7):1177-1191. PubMed ID: 32197571 [TBL] [Abstract][Full Text] [Related]
35. Cyclic versus Noncyclic Chelating Scaffold for Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082 [TBL] [Abstract][Full Text] [Related]
36. In Vitro and In Vivo Characterization of Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126 [No Abstract] [Full Text] [Related]
37. Preclinical ImmunoPET Imaging Using a Zr-89-Labeled Anti-CD146 Monoclonal Antibody for Diagnosis of Melanoma. Guo X; Hu M; Zhang Q; Liu J; Shi J; Tang Y; Liu S; Guo J; Kong Y; Zhu H; Yang Z Mol Pharm; 2024 Sep; 21(9):4490-4497. PubMed ID: 39077827 [TBL] [Abstract][Full Text] [Related]